 Prevention fetal growth retardation low-dose aspirin findings EPREDA trial efficacy low-dose aspirin fetal growth retardation randomised placebo-controlled double-blind trial secondary aim dipyridamole efficacy aspirin women weeks amenorrhoea twenty-five centres basis fetal growth retardation fetal death abruptio placentae previous pregnancy groups placebo mg/day aspirin mg/day aspirin mg/day dipyridamole remainder pregnancy first phase trial patients placebo group Mean birthweight treated placebo group SD vs difference CI frequency fetal growth retardation placebo group treated group vs frequencies stillbirth vs abruptio placentae vs placebo treated group benefits aspirin treatment patients previous poor outcomes second analysis aspirin vs aspirin dipyridamole significant differences excess maternal neonatal side-effects aspirin-treated patients